InvestorsHub Logo

jaiguruji7

07/29/21 5:47 AM

#75207 RE: OTCShotCaller #75007

Thanks OTCShotCaller for explaining this, awesome post!! This means that using the "NR2F6" Biotech, RGBP, can make all cancers cells less "malignant". THIS IS SUPER HUGE. Is this for all types of cancers or only some types of cancers?

"But yet the Crooked Naked Short Selling Counterfeiting Market Makers would have everyone think that ALL of RGBP's 24 Patents aren't even worth 2 CENTS!!! HA! HOW ROARING HILARIOUS! Anyone who believes this CON I have a Bridge in Arizona and a Flying Turtle I'd like to sell you! "

TOTALLY AGREED SIR, THIS IS VERY TRUE, WHO ARE THSE MMs trying to fool. THIS BIOTECH IS SUPR SUPER UNDERVALUED. WE ARE LOOKING AT MULTIPLE DOLLARS, THE BIG PHARMAS WILL BUYOUT RGBP FOR MULTIPLE DOLARS EASILY, BASED ON WHAT THEY POSSES.


The paragraph below from the street insider article is REALLY TSUNAMIC:

"We are optimistic that these initial positive data will lead the way forward into what we hope will be a new generation of immune stimulatory cancer drugs: Orally-available agents that will on the one hand unleash anticancer immune responses and on the other hand directly reprogram cancers rendering them less malignant," said Harry Lander, Ph.D., President and Chief Scientific Officer of Regen. "In parallel, we are continuing gene silencing studies with Santosh Kesari, M.D., Ph.D. in which we are precisely quantifying the correlation between inhibition of NR2F6 and immune stimulation. We believe that by using 2 independent approaches towards the same target, we will be in a position to accelerate clinical implementation and diversify our product pipeline." Dr. Santosh Kesari, a renowned neuro-oncologist who holds a doctorate in molecular biology, is with the John Wayne Cancer Institute at Providence Saint John's Health Center."

Grabbing more of these super duper cheapies.

GLTU and GLTA!!

SidVicious

07/29/21 7:12 AM

#75212 RE: OTCShotCaller #75007

Where are the in vivo Fda approved double blind clinical trials proving NR2F6 actually halts cancer? Oh, wait. There are none. But regen has the funding to do them, right? Oh wait. Nope, that’s not true either. But you’ll tell me that Onph does. Wait again, onco neither has the money nor connections to get that funding as they are still planning their plan. We know this because every month onco releases the same or but just slightly worded differently telling us the same thing about their plan. Good times!